ISRG
$445.88-1.27%
as of close, Oct 27, 2026
☾ AH $445.88 -1.27%
ISRG — Intuitive Surgical Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeSESEEEEEEEEEEEEEEEEEEEEE
100.0150.0200.0250.0300.0350.0400.0450.0500.0550.0600.0020.0M$445.88—20162019202120242026
2026-10-27
Price$445.88
MA20$399.62
MA50$460.17
Vol10.5M
Key stats#
Price data
- Price
- $445.88
- YTD price return
- -21.27%
- YTD total return
- -21.27%
- Market cap
- 154.6B
- Enterprise value
- 150.8B
- Shares outstanding
- 346.6M
- 52W low
- $328.57
- 52W high
- $603.88
- From 52W high
- -26.16%
- From 52W low
- +35.70%
- 52W range
- 43%
- Beta
- 1.46
Volume
- Rel volume
- 0.72×
- 30D volume
- 2.3M
- 30D $ vol
- 976.8M
Insider trading
- Insider net 1W
- −$11.9M
- Insider net 1M
- −$11.9M
- Insider net 3M
- −$16.8M
- Insider net 1Y
- −$41.3M
Form 4 transactions by trade date, as filed; latest on file 2026-10-23.
Fundamentals
- Sales (ttm)
- 11.6B
- Sales/share
- $33.40
- EPS (ttm)
- $8.28
- FCF (ttm)
- 3.6B
- FCF/share
- $10.38
- Book value/share
- $46.12
- Net margin
- 25.54%
- ROE
- 18.50%
- ROA
- 15.28%
- Current ratio
- 3.33
Growth (CAGR, ttm) · 10Y
- Sales
- +20.47%+19.11%+16.10%+16.00%
- Net income
- +7.66%+24.92%+11.85%+15.15%
- FCF
- +58.46%+42.03%+13.81%+13.45%
- Shares
- -2.22%-0.52%-0.60%-0.06%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +9.57%+24.90%+4.48%+14.92%
- Sales/share
- +23.20%+19.73%+16.80%+16.07%
- FCF/share
- +62.05%+42.77%+14.49%+13.51%
- Book value/share
- -3.44%+8.99%+7.62%+11.24%
- Price
- -19.13%+19.85%+5.02%+19.68%
- Total return
- -19.13%+19.85%+5.02%+19.68%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 53.9×
- P/OI (ttm)
- 47.1×
- Fwd P/E
- 36.4×
- P/S (ttm)
- 13.3×
- P/B (mrq)
- 9.7×
- P/FCF (ttm)
- 43.0×
- EV/Sales (ttm)
- 13.0×
- FCF yield (ttm)
- 2.33%
- Buyback yield (realized, 1y)
- 2.22%
- Shareholder yield (realized, 1y)
- 2.22%
- Buyback yield (cash, ttm)
- 2.99%
- Shareholder yield (cash, ttm)
- 2.99%
Vs own 10Y history
- P/E
- 32nd
- P/OI
- 30th
- P/S
- 18th
- P/B
- 66th
- P/FCF
- 13th
Bar = where today’s multiple sits in ISRG’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-1.27%
5D
+1.80%
1M
+10.04%
3M
+24.96%
YTD
-21.27%
1Y
-19.11%
5Y
+27.77%
Recent filings#
- Oct 20Earnings · Earnings release — EPS $2.53 vs $2.13 est. (+18.8%); revenue $3.05B (+22% y/y) 2.3%
- Jul 16Earnings · Earnings release — EPS $2.37 vs $2.02 est. (+17.3%); revenue $2.89B (+19% y/y) 14.1%
Financial statements
Open full ISRG financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
